scholarly article | Q13442814 |
P50 | author | Dirk Schadendorf | Q32649390 |
Axel Hauschild | Q32649861 | ||
Sabrina Angelini | Q40016284 | ||
Rajiv Kumar | Q42324767 | ||
Antje Sucker | Q61525189 | ||
Kari Hemminki | Q63213683 | ||
P2093 | author name string | Dominique Scherer | |
Friederike Egberts | |||
P Sivaramakrishna Rachakonda | |||
Franziska Mehnert | |||
P2860 | cites work | Genetics of Hair and Skin Color | Q28184398 |
Genetic determinants of hair, eye and skin pigmentation in Europeans | Q28254206 | ||
Gene expression signatures for tumor progression, tumor subtype, and tumor thickness in laser-microdissected melanoma tissues | Q33272950 | ||
MC1R variants increase risk of melanomas harboring BRAF mutations. | Q33715143 | ||
MC1R genotype modifies risk of melanoma in families segregating CDKN2A mutations | Q34020538 | ||
Relationship between germline MC1R variants and BRAF-mutant melanoma in a North Carolina population-based study | Q34179228 | ||
New insight into BRAF mutations in cancer | Q36701579 | ||
Changes in the presentation of nodular and superficial spreading melanomas over 35 years | Q36759522 | ||
BRAF(E600) in benign and malignant human tumours | Q36921234 | ||
In melanoma, RAS mutations are accompanied by switching signaling from BRAF to CRAF and disrupted cyclic AMP signaling | Q40224091 | ||
Melanocortin receptor 1 variants and melanoma risk: a study of 2 European populations | Q43776759 | ||
The association between MC1R genotype and BRAF mutation status in cutaneous melanoma: findings from an Australian population | Q44593803 | ||
MC1R germline variants confer risk for BRAF-mutant melanoma | Q79815917 | ||
P433 | issue | 12 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 2844-2848 | |
P577 | publication date | 2010-08-19 | |
P1433 | published in | Journal of Investigative Dermatology | Q3186921 |
P1476 | title | Association between the germline MC1R variants and somatic BRAF/NRAS mutations in melanoma tumors. | |
P478 | volume | 130 |
Q34674434 | A melanin-independent interaction between Mc1r and Met signaling pathways is required for HGF-dependent melanoma |
Q54441751 | Assessment of clinical parameters associated with mutational status in metastatic malignant melanoma: a single-centre investigation of 141 patients. |
Q40069925 | Associations of MC1R genotype and patient phenotypes with BRAF and NRAS mutations in melanoma |
Q45814416 | BRAF and MC1R in melanoma: different in head and neck tumors? |
Q54310382 | BRAF, NRAS and MC1R status in a prospective series of primary cutaneous melanoma. |
Q50224889 | Dermoscopic features of cutaneous melanoma are associated with clinical characteristics of patients and tumours and with MC1R genotype. |
Q39474116 | Detrimental effects of melanocortin-1 receptor (MC1R) variants on the clinical outcomes of BRAF V600 metastatic melanoma patients treated with BRAF inhibitors |
Q37392769 | Distribution of MC1R variants among melanoma subtypes: p.R163Q is associated with lentigo maligna melanoma in a Mediterranean population. |
Q38646092 | Melanoma Epidemiology and Prevention |
Q36919636 | Multiple congenital melanocytic nevi and neurocutaneous melanosis are caused by postzygotic mutations in codon 61 of NRAS |
Q57274188 | NRAS and BRAF Mutations in Cutaneous Melanoma and the Association with MC1R Genotype: Findings from Spanish and Austrian Populations |
Q36092451 | The melanomas: a synthesis of epidemiological, clinical, histopathological, genetic, and biological aspects, supporting distinct subtypes, causal pathways, and cells of origin |
Search more.